Media

Our scientists and their research often feature in print, radio, online and TV news.

Contact our media team to interview a scientist
t: +61 3 8572 2699
e: communications@hudson.org.au

In the media 2020

May

Could a Hormone Help Spur High Blood Pressure?
US News

Noxopharm receives FDA green light to progress towards Veyonda® trial
Kalkine Media
Finfeed
The Market Herald
Biotech Dispatch

Massive Australian Effort to beat coronavirus
Association of Australian Medical Research Institutes
The Courier-Mail

Reduce Tumor Activity in Breast Cancer
Targeted Oncology

Noxopharm marks important breakthroughs
The Market Herald

April

Request for approval from US FDA for clinical trials on COVID-19 patients
TechInvest
Mirage News
PharmaShots
Small Caps
The Market Herald
Kalkine Media

Eureka Research Fund for Immunology and Virology launched
Financial Review

The next pandemic: Firebreaks and host-directed therapies
Bio World

Tumor-fighting laser might also trigger an immune response in the body
Stockhead
Invion

Cancer drug investigated as anti-inflammatory for lethal conditions including COVID-19
Kalkine Media
Yahoo Finance
Business Wire
Small Caps
Morning Star
Reuters
Finance News Network
The National Tribune
Australian Manufacturing Forum
Mirage News
Small Caps

March

Coronavirus progress: Breakthrough research, first human vaccine trial
RACGP (Royal Australian College of General Practitioners)

February

Simple blood test measures the body’s immune response to improve ovarian cancer diagnosis
News Medical
Retail Pharmacy
Health Times
Biotech


January

Interview with Tasha Amour, CEO, Rare Ovarian Cancer Inc. 
ABC Illawarra, Wollongong

Edgar a stalwart of banking sector and proud humanitarian
The Australian

IVF treatment breakthroughs to create miracle babies
Herald Sun
Daily Telegraph Australia
Cairns Post
Gold Coast Bulletin
Northern Territory News
Adelaide Now
The Courier Mail

In the Media section